etoposide has been researched along with Benign Cranial Nerve Neoplasms in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hasegawa, Y; Itoh, K; Kato, N; Tanaka, T | 1 |
Assanelli, A; Baldini, L; Caligaris-Cappio, F; Ferrari, A; Ferreri, AJ; Foppoli, M; Frezzato, M; Frungillo, N; Ilariucci, F; Licata, G; Mappa, S; Marturano, E; Proserpio, I; Reni, M; SorarĂ¹, M; Stelitano, C; Vianello, F | 1 |
Chamberlain, MC; Grafe, MR | 1 |
Chamberlain, MC | 1 |
Bilaniuk, LT; Duhaime, AC; Galetta, SL; Liu, GT; Molloy, PT; Needle, M; Phillips, PC; Rorke, LB; Sutton, LN; Vojta, DD; Volpe, NJ | 1 |
Cohen, IJ; Horev, G; Kornreich, L; Michowiz, S; Shuper, A; Weitz, R; Zaizov, R | 1 |
2 trial(s) available for etoposide and Benign Cranial Nerve Neoplasms
Article | Year |
---|---|
Recurrent chiasmatic-hypothalamic glioma treated with oral etoposide.
Topics: Administration, Oral; Adolescent; Child; Child, Preschool; Cranial Nerve Neoplasms; Etoposide; Female; Glioma; Humans; Hypothalamic Neoplasms; Male; Neoplasm Recurrence, Local; Optic Chiasm; Salvage Therapy | 1995 |
Recurrent chiasmatic-hypothalamic glioma treated with oral etoposide.
Topics: Administration, Oral; Adolescent; Child; Child, Preschool; Cranial Nerve Neoplasms; Etoposide; Female; Glioma; Humans; Hypothalamic Neoplasms; Male; Neoplasm Recurrence, Local; Optic Chiasm; Salvage Therapy | 1995 |
4 other study(ies) available for etoposide and Benign Cranial Nerve Neoplasms
Article | Year |
---|---|
Long-term survival of diffuse large B cell lymphoma of the trigeminal region extending to the Meckel's cave treated by CHASER therapy: case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cecal Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cranial Nerve Neoplasms; Cyclophosphamide; Cytarabine; Dexamethasone; Etoposide; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Rituximab; Survivors; Trigeminal Nerve Diseases | 2014 |
Salvage chemoimmunotherapy with rituximab, ifosfamide and etoposide (R-IE regimen) in patients with primary CNS lymphoma relapsed or refractory to high-dose methotrexate-based chemotherapy.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cranial Irradiation; Cranial Nerve Neoplasms; Drug Administration Schedule; Drug Evaluation; Drug Resistance, Neoplasm; Etoposide; Eye Neoplasms; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Recurrence; Remission Induction; Retrospective Studies; Rituximab; Salvage Therapy; Survival Analysis; Transplantation, Autologous; Treatment Outcome | 2013 |
Gangliogliomas involving the optic chiasm.
Topics: Adolescent; Adult; Brain Neoplasms; Child; Combined Modality Therapy; Cranial Nerve Neoplasms; Cysts; Etoposide; Female; Ganglioglioma; Headache; Humans; Hypothalamus; Magnetic Resonance Imaging; Male; Mental Disorders; Neoplasm Invasiveness; Nerve Compression Syndromes; Optic Chiasm; Spinal Cord Neoplasms; Subarachnoid Space; Temporal Lobe; Ventriculoperitoneal Shunt; Vision Disorders; Visual Acuity | 1996 |
Visual pathway glioma: an erratic tumour with therapeutic dilemmas.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Child; Child, Preschool; Cranial Nerve Neoplasms; Cyclophosphamide; Dactinomycin; Etoposide; Female; Glioma; Humans; Infant; Magnetic Resonance Imaging; Male; Neurofibromatosis 1; Optic Chiasm; Optic Nerve Diseases; Vincristine; Visual Cortex | 1997 |